Background As human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a rare chronic neurological disease, large scale studies to …

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is an inflammatory neurologic disease caused by HTLV-I infection …

Background Human T-lymphotropic virus type 1 (HTLV-1) causes the debilitating
neuroinflammatory disease HTLV-1–associated myelopathy–tropical spastic paraparesis …

Background HTLV-I is the causal agent of adult T cell leukemia (ATLL) and HTLV-I-
associated myelopathy/tropical spastic paraparesis (HAM/TSP). Biomarkers are needed to …

The human T-cell lymphotropic virus type 1 (HTLV-1) infects 5-10 million people worldwide
and causes fatal and disabling diseases in a significant proportion of them. A chronic …

Purpose of Review To provide an evidence-based approach to the use of therapies that are
prescribed to improve the natural history of HTLV-1–associated myelopathy/tropical spastic …

Background Clear therapeutic guidelines for HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) are missing due to the lack of randomized double-blind controlled …

Opinion statement Human T-lymphotrophic virus 1 (HTLV-1)-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) is a disabling myelopathy, but clinical trials of specific drugs …

To clarify the existence of HAM/TSP presenting amyotrophic lateral sclerosis (ALS)-like
manifestations, we assayed HTLV-I proviral load in peripheral blood mononuclear cells …

Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a neural chronic
inflammation, called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) …